Minter Dialogue with Jay Godfrey
Jay Godfrey is an entrepreneur and cofounder of Nushama that provides medically supervised psychedelic treatments for sustained relief from depression, anxiety, chronic pain, PTSD and addiction. Previously, Jay built an eponymous fashion brand that had success around the world and was worn by celebrities, such as Jennifer Lopez, Viola Davis and Laverne Cox. In this discussion, we look at his career trajectory and pivot into Nushama. We explore the evolution of psychedelics and the pathologies it can help. We look at the business case and peak into the future of this exciting new field.
Please send me your questions — as an audio file if you’d like — to email@example.com. Otherwise, below, you’ll find the show notes and, of course, you are invited to comment. If you liked the podcast, please take a moment to rate it here.
To connect with Jay Godfrey:
Site(s) and references mentioned:
- Stolen Focus by Johann Hari
- Michael Pollan: How to Change your Mind
- James Fadiman: Psychedelic Explorer’s Guide
- Wisdom of Trauma by Maurizio and Zaya Benazzo
Further resources for the Minter Dialogue podcast:
Meanwhile, you can find my other interviews on the Minter Dialogue Show in this podcast tab, on Megaphone or via Apple Podcasts. If you like the show, please go over to rate this podcast via RateThisPodcast!
Music credit: The jingle at the beginning of the show is courtesy of my friend, Pierre Journel, author of the Guitar Channel. And, the new sign-off music is “A Convinced Man,” a song I co-wrote and recorded with Stephanie Singer back in the late 1980s (please excuse the quality of the sound!).
***If you like my writing and are interested in fostering more meaningful conversations in our society, please check out my Dialogos Substack. This newsletter will feature articles on why and how we can all improve our conversations, whether it’s at home, with friends, in society at large or at work. Subscription is free, but if you see value in it, you are welcome to contribute both materially and through your comments. Sign up here: